DVA vs THC
Davita Inc. and Tenet Healthcare Corp., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | DVA | THC |
|---|---|---|
| Revenue | $13.6B | $21.3B |
| Net income | $746.8M | $2.4B |
| Gross margin | — | — |
| Net margin | 5.5% | 11.1% |
| Return on equity | 159.1% | 56.4% |
| Diluted EPS | $9.84 | $15.49 |
| Dividend / share | — | — |
| Payout ratio | 0.0% | — |
| Free cash flow | $1.3B | $2.5B |
| Equity | $-651.1M | $4.2B |
| Net debt / equity | 69.19× | 2.42× |
| Current ratio | 1.29× | 1.76× |
| Revenue CAGR 5y | 3.4% | 3.9% |
| Profit CAGR 5y | −0.7% | 25.2% |
THC bills 1.6× the revenue of DVA, and keeps more of each dollar of revenue as profit (11.1% against 5.5%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | DVA | THC |
|---|---|---|
| FY2025 | $13.6B | $21.3B |
| FY2024 | $12.8B | $20.7B |
| FY2023 | $12.1B | $20.6B |
| FY2022 | $11.6B | $19.2B |
| FY2021 | $11.6B | $19.5B |
| FY2020 | $11.6B | $17.6B |
| FY2019 | $11.4B | $18.5B |
| FY2018 | $10.7B | $18.3B |
| FY2017 | $10.1B | $20.6B |
| FY2016 | $9.7B | $21.1B |
Net income by year
Bottom line
| Fiscal year | DVA | THC |
|---|---|---|
| FY2025 | $746.8M | $2.4B |
| FY2024 | $936.3M | $4.1B |
| FY2023 | $691.5M | $1.3B |
| FY2022 | $560.4M | $1.0B |
| FY2021 | $978.5M | $1.5B |
| FY2020 | $773.6M | $768.0M |
| FY2019 | $811.0M | $171.0M |
| FY2018 | $159.4M | $459.0M |
| FY2017 | $663.6M | $-320.0M |
| FY2016 | $879.9M | $176.0M |
Advertisement
AdSense · Rectangle 336×280